Alex Karnal (Deerfield)
Deerfield vaults to the top of cell and gene therapy CDMO game with $1.1B facility at Philadelphia's newest biopharma hub
Back at the beginning of 2015, Deerfield Management co-led a $10 million Series C for a private gene therapy startup …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
